Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease.
Nicole Quah Qin XianAhmed AlnahrawyRashmi AkshikarVickie LeePublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
MMF appears to be an effective and safe second-line immunosuppressive agent. Further studies aimed at elucidating optimal dosing regimens and ideal treatment duration will prove helpful.
Keyphrases